Andersen Olav M, Reiche Juliane, Schmidt Vanessa, Gotthardt Michael, Spoelgen Robert, Behlke Joachim, von Arnim Christine A F, Breiderhoff Tilman, Jansen Pernille, Wu Xin, Bales Kelly R, Cappai Roberto, Masters Colin L, Gliemann Jørgen, Mufson Elliott J, Hyman Bradley T, Paul Steven M, Nykjaer Anders, Willnow Thomas E
Max Delbrueck Center for Molecular Medicine, D-13125 Berlin, Germany.
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13461-6. doi: 10.1073/pnas.0503689102. Epub 2005 Sep 7.
sorLA (Sorting protein-related receptor) is a type-1 membrane protein of unknown function that is expressed in neurons. Its homology to sorting receptors that shuttle between the plasma membrane, endosomes, and the Golgi suggests a related function in neuronal trafficking processes. Because expression of sorLA is reduced in the brain of patients with Alzheimer's disease (AD), we tested involvement of this receptor in intracellular transport and processing of the amyloid precursor protein (APP) to the amyloid beta-peptide (Abeta), the principal component of senile plaques. We demonstrate that sorLA interacts with APP in vitro and in living cells and that both proteins colocalize in endosomal and Golgi compartments. Overexpression of sorLA in neurons causes redistribution of APP to the Golgi and decreased processing to Abeta, whereas ablation of sorLA expression in knockout mice results in increased levels of Abeta in the brain similar to the situation in AD patients. Thus, sorLA acts as a sorting receptor that protects APP from processing into Abeta and thereby reduces the burden of amyloidogenic peptide formation. Consequently, reduced receptor expression in the human brain may increase Abeta production and plaque formation and promote spontaneous AD.
sorLA(分选蛋白相关受体)是一种功能未知的1型膜蛋白,在神经元中表达。它与穿梭于质膜、内体和高尔基体之间的分选受体具有同源性,提示其在神经元运输过程中具有相关功能。由于阿尔茨海默病(AD)患者大脑中sorLA的表达降低,我们测试了该受体在细胞内运输以及淀粉样前体蛋白(APP)加工生成淀粉样β肽(Aβ)(老年斑的主要成分)过程中的作用。我们证明,sorLA在体外和活细胞中均与APP相互作用,且两种蛋白共定位于内体和高尔基体区室。在神经元中过表达sorLA会导致APP重新分布至高尔基体,并减少其加工生成Aβ,而在基因敲除小鼠中敲除sorLA的表达会导致大脑中Aβ水平升高,类似于AD患者的情况。因此,sorLA作为一种分选受体,可保护APP不被加工生成Aβ,从而减轻淀粉样肽生成的负担。因此,人类大脑中该受体表达降低可能会增加Aβ的产生和斑块形成,并促进自发性AD的发生。